eli lilly and company news

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of notable wins have me thinking this lead will widen. Earli

NBC News on MSN · 1d

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Reuters on MSN · 1d

Britain to study use of Lilly's weight loss drug to get people back to work

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high rate of long-term sickness that has become a major drag on the economy. Health minister Wes Streeting predicted the use of the drug - a competitor to Novo Nordisk's Ozempic - could help transform the health of the nation,

Eli Lilly's tirzepatide is off FDA's shortage list

Hosted on MSN · 1d

Should Eli Lilly Investors Worry About This Unexpected FDA Move?

Eli Lilly (NYSE: LLY) sells treatments for a wide variety of therapeutic areas, but one portfolio in particular has driven major gains in recent times. And that's the company's weight loss drugs. Lilly sells the compound tirzepatide under two different names -- Mounjaro for type 2 diabetes and Zepbound for weight loss.

FOX News on MSN · 22h

Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

Zacks.com on MSN · 1d

FDA to Reconsider Removal of Lilly's Obesity Drug From Shortage List

The FDA has agreed to review its decision to remove Eli Lilly’s LLY tirzepatide — the active ingredient used in diabetes drug Mounjaro and obesity drug Zepbound — from its shortage list. During this process,

How Eli Lilly Outpaces Nvidia—Here Is One Chart

Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...

15h

3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

bovnews2d

Eli Lilly And Co (LLY)’s Stock Surge: What You Need to Know

On Friday, Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $932.06 which represents a slight increase of $21.37 or 2.35% from the prior close of $910.69. The stock opened at ...

GlobalData on MSN13h

Eli Lilly will ‘build new way of doing science’ in UK amid £297m pledge to government

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

20h

This Artificial Intelligence Move Is One New Reason to Buy Eli Lilly Stock in 2024

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly ( LLY -1.74%) is taking a shot at developing one. With the appointment of a new ...

Eli Lilly: A Strong Buy on Robust Revenue Growth and Expanding Market Potential

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...

Eli Lilly and Company (NYSE:LLY) Shares Up 2.3% – Here’s What Happened

Eli Lilly and Company (NYSE:LLY – Get Free Report) shares rose 2.3% on Tuesday . The company traded as high as $920.28 and ...

1don MSN

Eli Lilly’s Zepbound to undergo first-of-its-kind study on economic impact

Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...

1don MSN

Eli Lilly to invest $364M in UK trial linking obesity drug to employment

The company has committed £279 million ($364 million) to support national efforts aimed at reducing obesity, a critical ...

中国日报网1d

Eli Lilly to expand medicine production in China

US pharmaceutical company Eli Lilly and Co recently announced a roughly $200 million expansion of its manufacturing site in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics